In these studies, they examined the peripheral blood, CSF, and CD8+ T cell clones from patients with MS exacerbations, patients with remissions, healthy individuals, and patients with other inflammatory neurological diseases. This evidence concerns the gene CD8A and myeloid sarcoma.